Fabio Fachin PhD

Dr. Fachin is Vice President of Cell Therapy Engineering and Manufacturing at Torque. Prior to joining Torque, Dr. Fachin held positions at Novartis’ Cell and Gene Therapy, where he led the development of the cell enrichment and manufacturing process for Kymriah, the first FDA-approved CAR-T immunotherapy product; and at MGH/Johnson & Johnson, where he led the engineering of point-of-care cancer diagnostic platforms. Dr. Fachin has more than 10 years of expertise in research and process engineering for cell therapy manufacturing, biotechnology diagnostics, and aerospace systems. Dr. Fachin holds a variety of patents, including “Methods of Making Chimeric Antigen Receptor-Expressing Cells.” He holds a PhD in Aerospace Engineering from the Massachusetts Institute of Technology.